CausalSentinel

Protein Dossier — EDAR (Tumor necrosis factor receptor superfamily member EDAR)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Heel bone mineral density (BMD) T-score automated -0.0291 0.00819 3.86e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: R04 Haemorrhage from respiratory passages 0.176 0.0742 0.0176 Wald ratio 1 cis NA
Eye problems or disorders: Diabetes related eye disease -0.234 0.104 0.0236 Wald ratio 1 cis NA
Neuroticism -0.0205 0.00909 0.0244 Wald ratio 1 cis NA
Serum cystatin C (eGFRcys) 0.0107 0.00477 0.0252 Wald ratio 1 cis NA
Sleep duration -0.0105 0.00494 0.0333 Wald ratio 1 cis NA
Cough on most days 0.0638 0.0304 0.0358 Wald ratio 1 cis NA
Non-cancer illness code self-reported: pernicious anaemia 0.201 0.0963 0.0371 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hyperthyroidism or thyrotoxicosis -0.181 0.0889 0.0421 Wald ratio 1 cis NA
Neo-neuroticism 0.494 0.254 0.0521 Wald ratio 1 cis NA
Diagnoses - main ICD10: M54 Dorsalgia 0.0839 0.0452 0.0637 Wald ratio 1 cis NA
Diagnoses - main ICD10: J33 Nasal polyp -0.213 0.115 0.0653 Wald ratio 1 cis NA
…and 86 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2977_7_2 EDAR Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

96 association rows across 75 traits (82 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
EDAR/F2R protein level ratio 2e-876 rs6750059 1 GCST90314577 no MR -> candidate analysis
Circulating EDAR levels 5e-868 rs148085735 4 GCST90860178 no MR -> candidate analysis
EDAR/PRDX5 protein level ratio 3e-803 rs6750059 1 GCST90314583 no MR -> candidate analysis
CRADD/EDAR protein level ratio 3e-788 rs6750059 1 GCST90314235 no MR -> candidate analysis
EDAR/ENO2 protein level ratio 5e-774 rs6750059 1 GCST90314574 no MR -> candidate analysis
DBI/EDAR protein level ratio 1e-757 rs6750059 1 GCST90314408 no MR -> candidate analysis
ANXA3/EDAR protein level ratio 6e-751 rs6750059 1 GCST90313280 no MR -> candidate analysis
EDAR/F11R protein level ratio 7e-724 rs6750059 1 GCST90314576 no MR -> candidate analysis
EDAR/SNAP23 protein level ratio 1e-713 rs6750059 1 GCST90314587 no MR -> candidate analysis
EDAR/TXNDC5 protein level ratio 1e-690 rs6750059 1 GCST90314593 no MR -> candidate analysis
DBNL/EDAR protein level ratio 1e-673 rs6750059 1 GCST90314416 no MR -> candidate analysis
CD69/EDAR protein level ratio 2e-654 rs6750059 1 GCST90313875 no MR -> candidate analysis
…and 63 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1771 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
autosomal recessive hypohidrotic ectodermal dysplasia 0.928 established (curated) no MR -> candidate analysis
hypohidrotic ectodermal dysplasia 0.953 established (curated) no MR -> candidate analysis
ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant 0.87 established (curated) no MR -> candidate analysis
autosomal dominant hypohidrotic ectodermal dysplasia 0.526 established (curated) no MR -> candidate analysis
Oligodontia 0.842 established (curated) no MR -> candidate analysis
ectodermal dysplasia syndrome 0.745 established (curated) no MR -> candidate analysis
hereditary disease 0.742 established (curated) no MR -> candidate analysis
mitochondrial neurogastrointestinal encephalomyopathy 0.654 established (curated) no MR -> candidate analysis
Alpers syndrome 0.654 established (curated) no MR -> candidate analysis
mitochondrial DNA depletion syndrome 4a 0.654 established (curated) no MR -> candidate analysis
androgenetic alopecia 0.596 common-variant locus no MR -> candidate analysis
hair morphology 0.51 common-variant locus no MR -> candidate analysis
vascular disorder 0.461 common-variant locus no MR -> candidate analysis
facial morphology 0.46 common-variant locus no MR -> candidate analysis
Left bundle branch block 0.438 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 15 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Tumor necrosis factor receptor superfamily member EDAR)
gnomAD constraint pLI=3.6e-10, LOEUF=0.972 — LoF-tolerant
GWAS Catalog 50 unique SNPs / 99 rows
ClinVar 455 records; 7 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance